stock
QTTB · Q32 Bio Inc.
What Q32 Bio Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live QTTB price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on QTTB.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 29,769,466 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- 31.9%
- ROA
- 29.1%
Health
- Current ratio
- 20.3x
- Debt/equity
- —
Deep value
- NCAV
- $99.68M
- NCAV per share
- $3.35
- Price/NCAV
- Locked
- NNWC
- $96.31M
- NNWC per share
- $3.24
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$9.12M | -$8.95M | 10-Q filed 2026-08-05 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | -$7.72M | -$7.61M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | — | —Gross profit: unreported by this company. | $45.88M | $57.71M | DEF 14A filed 2026-04-30 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | — | —Gross profit: unreported by this company. | -$7.58M | -$7.39M | 10-Q filed 2025-11-13 |
| 2025-06-30 | — | —Gross profit: unreported by this company. | -$9.17M | -$9.49M | 10-Q filed 2026-08-05 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | -$12.23M | -$11.03M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $0 | —Gross profit: unreported by this company. | -$14.53M | -$14.16M | DEF 14A filed 2026-04-30 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $0 | —Gross profit: unreported by this company. | -$18.81M | -$17.59M | 10-Q filed 2025-11-13 Assembled from more than one filing; the filing above is only the newest of them. |
- Assets
- $115.87M
- Equity
- $105.91M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $53.74M | $16.90M | $29.80M | -$33.54M |
| 2024-12-31 | $0 | -$66.10M | -$47.70M | -$67.79M |
| 2023-12-31 | $1.16M | -$48.26M | -$53.70M | -$18.68M |
| 2022-12-31 | $3.21M | -$133.28M | -$5.00M | -$114.95M |
| 2021-12-31 | $33.97M | -$95.95M | -$95.76M | -$112.15M |
| 2020-12-31 | $2.70M | -$130.26M | -$128.69M | -$98.06M |
| 2019-12-31 | $1.67M | -$109.94M | -$103.92M | -$113.19M |
| 2018-12-31 | $5.32M | -$59.93M | -$55.58M | -$67.50M |
| 2017-12-31 | — | -$29.66M | -$29.99M | $4.52M |
Company filings
since Fri Jul 17 · 6 offering filings in 12 months · since Fri Apr 24
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 308-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 148-KResults
ResultsAug 58-KMaterial agreement
Material agreementJul 158-KOther event
Other eventJul 138-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventJul 138-K
5% owners ()
Point72 Asset Management, L.P.
Stake update
Sirenia Capital Management LP
Stake update
Opaleye Management Inc.
Stake update
ORBIMED ADVISORS LLC
Stake update
Boxer Capital Management, LLC
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Morrison Jodie Pope
CEO, Director
Sale$163,033Aug 27, 4:10 PM ET
Kalowski Lee
CFO and President
Sale$65,776Aug 27, 4:10 PM ET
Violette Shelia M.
Chief Scientific Officer
Sale$46,335Aug 27, 4:10 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named QTTB, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about QTTB.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on QTTB come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the QTTB board